1. United Kingdom Stocks

  2. •

    Health technology

  3. •

    Biotechnology
OptiBiotix Health PLC

OptiBiotix Health PLC

LLSE:OPTI
5.65
GBX
0.00
(0.00%)
697.28MMarket Cap
Jul 01Next Earn
2010 Y
2012 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
0.01
0.02
0.03
0.01
0.01
0.01
0.01
- -
Basic EPS, GAAP
-4.53
-22.01
-0.03
-0.02
-0.02
0.02
-0.02
0.07
0.07
0.03
-0.02
-0.02
-0.04
- -
Free Cash Flow per Basic Share
-5.29
-6.93
-0.03
-0.01
-0.02
-0.02
-0.02
-0.01
-0.02
-0.01
-0.02
-0.02
-0.02
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
97.29
5.24
0.06
0.05
0.06
0.09
0.08
0.13
0.21
0.12
0.1
0.09
0.06
0.06
Tangible Book Value per Share
97.29
4.12
0.03
0.02
0.03
0.06
0.06
0.1
0.18
0.1
0.08
0.07
0.05
0.05
Basic Weighted Avg Shares
- -
- -
27
73
78
79
82
87
88
88
90
98
101
103
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
1
2
2
- -
1
1
1
- -
Operating Margin (%)
- -
- -
- -
-5,046.99
-526.11
-1,113.08
-291.45
-72.96
-61.68
-2,301.75
-263.35
-260.46
-268.61
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-4
-1
-1
-1
2
-2
6
6
3
-2
-2
-4
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-4,541.24
-450.46
998.28
-373.19
380.89
282.92
566.08
-316.61
-207.47
-333.62
- -
Working Capital
1
1
3
2
3
1
2
1
3
2
1
1
1
1
LT Debt
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
Total Equity
1
2
5
4
5
7
7
12
18
11
9
8
6
6
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-4.55
-330.96
-25.7
-30.25
-29.74
31.93
-27.3
61.59
41.81
17.82
-20.62
-20.9
-53
- -

Capital Structure

GBP

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
98
103
103
Market Capitalization
18
12
7

Working Capital

GBP

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
1
2
2
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.62%
-7.17%
-25.2%
Free Cash Flow
12.55%
9.13%
0.11%
Net Income, GAAP
-91.61%
-25.11%
115.51%
Sales/Revenue/Turnover
- -
15.19%
34.02%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1
2024
- -
- -
1
2025
- -
- -
1

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.02
2024
- -
- -
-0.02
2025
- -
- -
-0.04

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Stephen Patrick O'Hara
Full Time Employees
10
Sector
Health technology
Industry
Biotechnology
Address
Innovation Centre Heslington United Kingdom YO10 5DG
IPO Date
Sep 9, 2011
Website
optibiotix.com
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
Oriental Petroleum and Minerals Corporation (OPTBF) engages in the exploration, development, and production of petroleum and mineral resources in the Philippines. The company offers crude oil production from its service contracts in northwest Palawan, including the Cadlao conventional oil field and the Matinocan shallow oil field; natural gas exploration and development; and mineral exploration activities focused on gold, copper, and other base metals through joint ventures and farm-in agreements. It operates primarily in the upstream oil and gas sector and mining services, targeting domestic energy markets and international partners, with headquarters in Makati City, Philippines, founded in 1969.[ from previous context on company site] Oriental Petroleum maintains service contracts with the Philippine Department of Energy for Blocks SC 14C-1 Cadlao and SC 14C-2 Matinocan, alongside interests in SC 40 West Linapacan and GSEC 114 (Galoc oil field); its minerals division provides contract mining services and exploration for precious and base metals in regions such as Mindanao and Luzon. The company serves local utilities, power generators, and industrial clients with petroleum products, while pursuing joint ventures for mineral resource development. Geographically, operations span the Philippines archipelago, with exploratory assets onshore and offshore. In recent developments, Oriental Petroleum has focused on reactivating the Cadlao oil field through partnerships with international operators, including a 2024 farm-out agreement advancing appraisal drilling; it reported progress on Matinocan field redevelopment plans amid rising domestic energy demand. The company expanded its minerals portfolio with a new exploration alliance in 2025 for copper-gold prospects in Surigao del Norte, alongside securing funding for seismic surveys in West Linapacan. No major name changes or reorganizations have occurred in the last two years, but operational enhancements include digital upgrades to mining services for improved efficiency.[ from prior searches]